Epigenetic drug screening defines a PRMT5 inhibitor–sensitive pancreatic cancer subtype

Date Issued
2022
Author(s)
Orben, Felix
Lankes, Katharina
Schneeweis, Christian
Hassan, Zonera
Jakubowsky, Hannah
Krauß, Lukas
Boniolo, Fabio
Schäfer, Arlett
Murr, Janine
DOI
10.1172/jci.insight.151353